生物活性 | |||
---|---|---|---|
描述 | Acetaminophen (Paracetamol) is a selective cyclooxygenase-2 (COX-2) inhibitor with an IC50 of 25.8 μM; is a widely used antipyretic and analgesic agent. In vitro, acetaminophen elicited a 4.4-fold selectivity toward COX-2 inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for COX-2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX-1) and 83% (COX-2). Acetaminophen plasma concentrations remained above the in vitro IC(50) for COX-2 for at least 5 h postadministration. Ex vivo IC(50) values (COX-1: 105.2 micromol/L; COX-2: 26.3 micromol/L) of acetaminophen compared favorably with its in vitro IC(50) values[3]. Moreover, detrimental effect of APAP (Acetaminophen) on cell viability was suppressed in the presence of HV110 (Lactobacillus fermentum BGHV110 strain) which was linked with increased conversion of LC3 protein and p62/SQSTM1 protein degradation. Additionally, higher p62/SQSTM1 and PINK1 mRNA transcription were noticed in cells co-treated with APAP/HV110, simultaneously[4]. Acetaminophen is a hormone disrupter (ie, it interferes with sex and thyroid hormone function essential for normal brain development) and thus may not be considered a safe drug during pregnancy[5]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00377364 | Asthma Rheuma... 展开 >>tic Disease 收起 << | Phase 4 | Completed | - | United States, Texas ... 展开 >> UT Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 收起 << |
NCT01827475 | - | Completed | - | - | |
NCT00377364 | - | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
6.62mL 1.32mL 0.66mL |
33.08mL 6.62mL 3.31mL |
66.16mL 13.23mL 6.62mL |
参考文献 |
---|
[5]Aminoshariae A, Khan A. Acetaminophen: old drug, new issues. J Endod. 2015;41(5):588-593 |